Propanc has raised $100 million for cryptocurrency reserves and cancer therapy research.
BlockBeats News, November 11th, according to The Block, Propanc Biopharma, a US-listed biopharmaceutical company (Nasdaq stock code: PPCB), has announced that it has secured up to $100 million in funding from the family office Hexstone Capital, which is active in the Bitcoin, Ethereum, Solana, Dogecoin, and other digital asset spaces. The private placement transaction was structured through convertible preferred stock, with Propanc receiving an initial investment of $1 million and up to $99 million in additional funding over the next year.
The funds will be used to build Propanc's digital asset portfolio and accelerate the development of its flagship cancer therapy, PRP, which is currently scheduled to begin its first human trials in 2026. The company did not specify which digital assets it plans to acquire. The financing news did not halt the decline in Propanc's stock price. On Monday, PPCB's stock price fell by 4%, dropping below $1, with a cumulative decrease of 43% over the past month.
You may also like
Looking at Stripe's ambitions and the future of stablecoins from OUSD
Do you want to buy CRCL?
Wosh: Inflation has cooled in recent weeks, AI is reshaping the economy, and forward guidance has lost its necessity
The most secretive AI winner
Former ByteDance employee's account: How I started with two Pinduoduo hard drives and made six times the profit with Seagate to achieve financial freedom?
MiCA reshuffle begins, Binance temporarily bids farewell to the EU
How does Gate redo "buying and selling stocks" from the cryptocurrency world to the stock market?
Visa and Mastercard join 140 giants to launch a new stablecoin, but the impact on the market landscape may still be limited
Circle CEO responds to OUSD's challenge: Stablecoins are a winner-takes-all business, and we will not slow down
Argentina vs Cape Verde: When a Record-Breaking Legend Meets an Unbreakable Underdog
WEEX exclusive pre-match analysis of Argentina vs Cape Verde, exploring Messi-led Argentina’s dominance and Cape Verde’s historic defensive breakout, with a breakdown of volatility, structure, and match dynamics.



